Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/2003
09/09/2003US6617102 Screening for a bioactive agent capable of interfering with the binding of a protein; use in diagnosis and treatment of cancer
09/09/2003CA2145630C Microorganisms for the production of tryptophan and process for producing the same
09/07/2003WO2003074701A1 p18AβrP GENE AND p18AβrP PROTEIN, NOVEL GENE/PROTEIN (p60TRP) INTERACTING THEREWITH TO INHIBIT CELL DEATH AND CELL DEATH PROMOTER
09/07/2003CA2432937A1 P18abrp gene and p18abrp protein, and novel gene/protein (p60trp) suppressing cell death and substances promoting cell death by interaction with the same
09/05/2003CA2374527A1 Gene of enzyme activity to generate lachrymatory factor
09/04/2003WO2003073067A2 Rna detection enzymes
09/04/2003WO2003072813A2 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy
09/04/2003WO2003072789A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003WO2003072787A2 Method for detection of leptin receptor ligands
09/04/2003WO2003072786A1 Process for producing l-threonine with the use of bacterium beloniging to the genus escherichia
09/04/2003WO2003072785A2 Fermentation process
09/04/2003WO2003072784A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
09/04/2003WO2003072783A1 Process for producing n-acetylneuraminic acid
09/04/2003WO2003072782A1 Echinococcus antigen, gene encoding the same and method of diagnosing human hydatidosis
09/04/2003WO2003072781A1 Mite galectin
09/04/2003WO2003072776A1 Gene encoding novel enzyme catalyzing glycosyl transfer reaction and process for producing the enzyme
09/04/2003WO2003072774A1 K+ transporter and use thereof
09/04/2003WO2003072773A1 Fused protein having glucuronyl transferase activity
09/04/2003WO2003072770A1 Novel dehydrogenase and gene encoding the same
09/04/2003WO2003072762A1 Benzene-utilizing rhodococcus and plasmid prepared thereby
09/04/2003WO2003072740A2 Novel type-1 cytokine receptor glm-r
09/04/2003WO2003072739A2 Trans-splicing mediated imaging of gene expression
09/04/2003WO2003072733A2 Modified bace
09/04/2003WO2003072732A2 Methods of making hypermutable cells using pmsr homologs
09/04/2003WO2003072730A2 Secondary metabolite congener distribution modulation
09/04/2003WO2003072715A2 Gasp1: a follistatin domain containing protein
09/04/2003WO2003072714A2 Follistatin domain containing proteins
09/04/2003WO2003072698A2 Surface proteins of leptospira
09/04/2003WO2003072609A1 Tick chitinase
09/04/2003WO2003072608A1 Anti-human tenascin monoclonal antibody
09/04/2003WO2003072594A2 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
09/04/2003WO2003072133A2 Immunostimulatory agent comprising a biomass of methanotrophic bacterium
09/04/2003WO2003072044A2 Selection of poultry eimeria strains through extra-intestinal sporozoites
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003072014A2 Minicell compositions and methods
09/04/2003WO2003071933A2 Novel compositions and methods for cancer
09/04/2003WO2003071883A1 Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations
09/04/2003WO2003053224A3 Novel compositions and methods for cancer
09/04/2003WO2003040379A3 Modulating urea degradation in wine yeast
09/04/2003WO2003033681A3 Composition comprising a lactobacillus pentosus strain and uses thereof
09/04/2003WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/04/2003WO2003027297A9 PROCESS FOR PRODUCING α2,3/α2,8-SIALYLTRANSFERASE AND SIALIC ACID-CONTAINING COMPLEX SUGAR
09/04/2003WO2003008616A3 PROCESS FOR THE PREPARATION OF L-AMINO ACIDS USING STRAINS OF THE ENTEROBACTERIACEAE FAMILY WHICH CONTAIN AN ATTENUATED aceK GENE
09/04/2003WO2003004525A8 Isolation and purification of plasmodium falciparum merozoite protein-142
09/04/2003WO2002103016A3 Human tachykinin-related splice variants and compositions thereof
09/04/2003WO2002101080A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002101068A3 Process for the preparation of d-pantothenic acid and/or salts thereof
09/04/2003WO2002101062A3 Process for the preparation of d-pantothenic acid and/or salts thereof
09/04/2003WO2002101044A3 Brain expressed gene and protein associated with bipolar disorder
09/04/2003WO2002097395A3 P-cadherin as a target for anti-cancer therapy
09/04/2003WO2002094870A8 Proteins and nucleic acids encoding same
09/04/2003WO2002083858A8 Methods to inhibit viral replication
09/04/2003WO2002083853A3 Method for enhancing the translation and expression of recombinant proteins
09/04/2003WO2002079465A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
09/04/2003WO2002070703A3 Cell visual characteristic-modifying sequences
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002061041A3 Solubility reporter gene constructs
09/04/2003WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof
09/04/2003WO2002059313A3 G-protein coupled receptors and nucleic acids encoding same
09/04/2003WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation
09/04/2003WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002046353A3 Self-spreading microbiological culture device
09/04/2003WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide
09/04/2003WO2002036807A3 Compositions and methods relating to breast specific genes and proteins
09/04/2003WO2002036770A3 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
09/04/2003WO2002033109A3 Fermentation method for production of heterologous gene products in lactic acid bacteria
09/04/2003WO2002022667A3 Twin-arginine translocation in bacillus
09/04/2003WO2002016421A9 Altered ospa of borrelia burgdorferi
09/04/2003WO2001066595A9 Human fgf-23 gene and gene expression products
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030167529 Plants synthesizing a modified starch, a process for the generation of the plants, their use, and the modified starch
09/04/2003US20030167525 Desaturase genes and uses thereof
09/04/2003US20030167522 Obtained from Bacillus thuringiensis (cry proteins); for activity against corn rootworm pests
09/04/2003US20030167521 Genetic engineered insecticide
09/04/2003US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences
09/04/2003US20030167482 Novel semaphorin Z and gene encoding the same
09/04/2003US20030166911 Hybrid nucleic acids; genetic engineering
09/04/2003US20030166908 Seafood protein; measuring water absorption of fish bladder
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166897 Diagnosis, therapy cancer; transgenic animal
09/04/2003US20030166891 Novel Bt toxin receptors from lepidopteran insects and methods of use
09/04/2003US20030166879 Adjustable threshold switch
09/04/2003US20030166875 Fibroblast growth factor homologous factor-2 and methods of use
09/04/2003US20030166861 Human blue-light photoreceptor hCRY2
09/04/2003US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents
09/04/2003US20030166854 Allelic variant of human STAT3
09/04/2003US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound
09/04/2003US20030166848 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin
09/04/2003US20030166847 Novel human leptin receptor gene-related protein
09/04/2003US20030166844 Immunologenic polypeptides; therapy for Streptococcus infections
09/04/2003US20030166838 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives
09/04/2003US20030166832 Methods and compositions for impairing multiplication of HIV-1
09/04/2003US20030166715 Use of vitaletheine modulators in the prophylaxis and treatment of disease
09/04/2003US20030166587 Compounds and methods for modulating activation of NF-kB
09/04/2003US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions
09/04/2003US20030166543 Functional antagonists of hedgehog activity
09/04/2003US20030166532 Annexin V, is used to prevent thrombosis without increasing hemorrhage. Annexin binds to phosphatidylserine on the outer surface of cell membranes, thereby preventing binding of the prothrombinase complex necessary for thrombus formation.
09/04/2003US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
1 ... 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 ... 1489